Article info
PDFOriginal article
Excellent outcome of minimal residual disease-defined low-risk patients is sustained with more than 10 years follow-up: results of UK paediatric acute lymphoblastic leukaemia trials 1997–2003
- Correspondence to Dr Jack Bartram, Department of Haematology, Level 2 Camelia Botnar Laboratory, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK; j.bartram{at}ucl.ac.uk
Citation
Excellent outcome of minimal residual disease-defined low-risk patients is sustained with more than 10 years follow-up: results of UK paediatric acute lymphoblastic leukaemia trials 1997–2003
Publication history
- Received August 25, 2015
- Revised January 19, 2016
- Accepted January 20, 2016
- First published February 10, 2016.
Online issue publication
April 19, 2016
Article Versions
- Previous version (19 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/